Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Development of resistance to imatinib mesylate (IM) in chronic myeloid leukemia (CML) patients is mediated by different mechanisms that can be classified as BCR-ABL dependent or BCR-ABL independent pathways. BCR-ABL dependent mechanisms are most frequently associated with point mutations in tyrosine...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Elias, Marjanu Hikmah, Baba, Abdul Aziz, Husin, Azlan, Abdullah, Abu Dzarr, Hassan, Rosline, Sim, Goh Ai, Wahid, S. Fadilah Abdul, Ankathil, Ravindran
Formato: Artigo
Idioma:Inglês
Publicado: PAGEPress Publications 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555211/
https://ncbi.nlm.nih.gov/pubmed/23355941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2012.e23
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares